Read + Share
Amedeo Smart
Independent Medical Education
Rolfes L, Meuth SG. Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-"Yes". Mult Scler 2021 Dec 21:13524585211055593. doi: 10.1177/13524585211055593.PMID: 34931903
Email
LinkedIn
Facebook
Twitter
Privacy Policy